---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-24-009508"
form_type: "8-K"
ticker: "CBIO"
cik: "0001253689"
company_name: "CRESCENT BIOPHARMA, INC."
filed_at: "2024-06-26T23:59:59+00:00"
generated_at: "2026-06-01T01:20:33.379767+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# GlycoMimetics receives Nasdaq bid price deficiency notice; 180 days to regain compliance

## Summary
- Received Nasdaq notice on June 21, 2024 for bid price below $1.00 for 30 consecutive business days.
- Has until December 18, 2024 to regain compliance by closing at $1.00+ for 10 consecutive days.
- If not compliant, may transfer to Nasdaq Capital Market for an additional 180-day compliance period.
- Failure to regain compliance could result in delisting of GLYC common stock from Nasdaq.
- Company intends to monitor bid price and consider options; no assurance of regaining compliance.

## SEC filing metadata
- accession: 0001558370-24-009508
- form_type: 8-K
- ticker: CBIO
- cik: 0001253689
- company_name: CRESCENT BIOPHARMA, INC.
- filed_at: 2024-06-26T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1253689/000155837024009508/0001558370-24-009508-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1253689/000155837024009508/glyc-20240621x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-24-009508
- JSON: https://secwatch.observer/filing/0001558370-24-009508.json
- Plain text: https://secwatch.observer/filing/0001558370-24-009508.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.